Company |
Company |
Value (M) |
Type/product area |
Terms/details |
Date |
APRIL | |||||
Dandrit Biotech A/S (Copenhagen, Denmark) |
Riyadh Pharma Co. Ltd. (Riyadh, Saudi Arabia) |
ND |
Partnership in which Riyadh will be responsible for manufacturing Dandrit's dendritic cell cancer vaccine, MCV, in the Middle East |
Financial terms were not disclosed |
4/24/15 |
Novabay Pharmaceuticals Inc. (Emeryville, Calif.) |
Amerisourcebergen Corp. (Chesterbrook, Pa.) |
ND |
U.S. distribution agreement for Avenova, its prescription lid and lash hygiene product |
The product is designed to manage eye conditions such as blepharitis, Meibomian gland dysfunction and associated dry eye |
4/2/15 |
MAY | |||||
Iroko Pharmaceuticals LLC (Philadelphia) |
Litha Healthcare Group (Gauteng, South Africa) |
ND |
Licensing agreement for the exclusive rights to market and sell Zorvolex (diclofenac) capsules in Angola, Botswana, Lesotho, Madagascar, Malawi, Mauritius, Mozambique, Namibia, Republic of South Africa, Seychelles, Swaziland, Tanzania and Zambia |
Lithia will be responsible for obtaining regulatory and pricing approval, and will provide marketing and distribution |
5/7/15 |
Lucerne Biosciences LLC (Wilmington, Del.) |
LCS Group LLC (New Haven, Conn.) |
ND |
Exclusive license agreement for rights to commercialize U.S. Patent No. 8,318,813 and U.S. Patent Application No. 14/465,249, both titled "Method of Treating Binge Eating Disorder" (BED) |
LCS Group's commercialization is planned through Dublin-based Shire plc's U.S. group's national marketing campaign of the drug lisdexamfetamine dimesylate to treat BED |
5/15/15 |
Notes The date indicated refers to the BioWorld Today issue in which the news item can be found. For more information about individual companies and/or products, see Thomson Reuters Cortellis. |